<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7"><gtr:id>D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7</gtr:id><gtr:name>Birmingham Heartlands Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9AB78999-CAB7-401A-B3A4-0068465A9D2F"><gtr:id>9AB78999-CAB7-401A-B3A4-0068465A9D2F</gtr:id><gtr:name>Indian Institute of Science Bangalore</gtr:name><gtr:address><gtr:line1>2nd Floor, CAOS Building</gtr:line1><gtr:postCode>560 012</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>India</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7"><gtr:id>D3B5235B-CC4A-4B38-8E39-5179BAFB4DE7</gtr:id><gtr:name>Birmingham Heartlands Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9AB78999-CAB7-401A-B3A4-0068465A9D2F"><gtr:id>9AB78999-CAB7-401A-B3A4-0068465A9D2F</gtr:id><gtr:name>Indian Institute of Science Bangalore</gtr:name><gtr:address><gtr:line1>2nd Floor, CAOS Building</gtr:line1><gtr:postCode>560 012</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>India</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/292C50B8-7B92-49EB-B4D7-F289D69CFA42"><gtr:id>292C50B8-7B92-49EB-B4D7-F289D69CFA42</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:surname>Buxton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117585867"><gtr:id>3CB593D2-0346-4A3F-9350-8CCF83F332EE</gtr:id><gtr:title>Gene expression and pathogenicity in mycobacteria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117585867</gtr:grantReference><gtr:abstractText>Tuberculosis (TB) is the leading cause of death worldwide due to an infectious disease, a situation exacerbated by its deadly synergy with AIDS. Annually approximately 2 million people die from TB. Even in the UK and other western countries there is a continuing significant increase in the disease in recent years. The situation is not helped by the limited effectiveness, at least in some part of the world, of the widely used vaccine BCG. Moreover there is a great threat from bacteria that are resistant to treatment with conventional anti-TB drugs, resulting in a disease that is essentially non-treatable unless new antibiotics are discovered. Thus strategies for developing new approaches to the treatment and prevention of TB are a high public health priority. Research at the National Institute for Medical Research is aimed at trying to gain a better understanding of the way in which the bacterium which causes TB is able to infect people and how that process might be interrupted. Using molecular genetics the researchers are identifying some of the key molecules produced by the bacterium and the infected cells, which enable the infection to either progress or be eliminated. These molecules are then being used to screen for novel anti-TB drugs in collaboration with MRC-Technology.</gtr:abstractText><gtr:technicalSummary>Mycobacteria are a group of bacteria that include some of the most important causes of human infectious disease. Different mycobacterial species are the causes of tuberculosis (TB), the leading cause of death worldwide due to an infectious disease, and leprosy, a disease that results in deformity and disability in millions of people. The objective of this work is to understand the mechanisms which underlie the pathogenicity of the causative agent of human TB, Mycobacterium tuberculosis and to search for new therapeutic agents against it. In this project we are attempting to identify key molecules of M. tuberculosis which enable it to survive and grow inside macrophages, the host cells which are invaded by the bacteria in these diseases. We can also monitor the ways in which the macrophages respond to this invasion by the bacteria. By understanding this interaction we hope to develop new approaches for treating and/or preventing these diseases. This work involves the use of genetic approaches to identify molecules which are important for regulating gene expression and for growth and survival of M. tuberculosis inside macrophages. By introducing mutations into bacteria we can ask whether such changes reduce the ability of the bacteria to cause disease; if so, then the genes which we have mutated can be characterised to give us a better understanding of their function and thus to provide important information about how the bacteria cause TB. We are also able to analyse changes in gene expression that occur within macrophages following infection in order to identify key molecules which are produced by the host and which may influence the outcome of the infection. The changes in gene expression, in both bacteria and host cells, are monitored using whole genome DNA microarrays, either a spotted microarray for M. tuberculosis, or an Affymetrix microarray for host (mouse or human) cells. Having identified candidate genes in M. tuberculosis, deletions of them are derived using homologous recombination techniques, and the effect of the deletion is investigated both by infecting macrophages in vitro and by infecting mice. Identification of the key molecules involved in determining the outcome of infection is a starting point for identifying potential new drug targets. We can produce recombinant protein molecules and develop assays as the basis for screens for new anti-TB drugs. These high throughput screens are performed in collaboration with MRC-Technology. Since the emergence of multiple drug-resistant strains of M. tuberculosis and limitations in the effectiveness of the existing vaccine BCG represent an enormous public health challenge, such approaches are extremely important for the future control of TB and related diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1857947</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Global Health Institute</gtr:department><gtr:description>Regulation of the ESX-1 secretion system in Mycobacterium tuberculosis</gtr:description><gtr:id>B987F88C-4BA4-42DF-94F8-F86140F0E0AE</gtr:id><gtr:impact>PMID: 22155774</gtr:impact><gtr:outcomeId>gncrZYxDzMQ-1</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.</gtr:partnerContribution><gtr:piContribution>Intellectual and experimental contributions. Provision of mutant bacteria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>Evaluation of inhibitors of Mycobacterium tuberculosis protein kinases.</gtr:description><gtr:id>49E4359E-AB53-4854-8B7A-497910F9D71D</gtr:id><gtr:impact>MRC-Technology Development Gap Fund award - 2006. PMID:21482481. PMID: 22469702.</gtr:impact><gtr:outcomeId>8892FD41FBA-1</gtr:outcomeId><gtr:partnerContribution>Screening of compound libraries, discussion and analysis of results.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>In vitro and in vivo experiments to evaluate lead compounds, discussion and analysis of results.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>cAMP receptor protein of Mycobacterium tuberculosis.</gtr:description><gtr:id>7B35D4D4-4275-4A0F-A9D1-AE9E277844DD</gtr:id><gtr:impact>PMID: 15882420. Wellcome joint Project Grant (078731/Z/05/Z) with University of Sheffield - 2007. PMID:20028978. PMID:20929442.</gtr:impact><gtr:outcomeId>45A5A57F45E-3</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.Provision of DNA microarrays.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Use of chromatin immunoprecipitation to study transcription factor distribution on the Mycobacterium tuberculosis chromosome.</gtr:description><gtr:id>93DB8CCF-3FB6-4302-A099-4B13EBC855B6</gtr:id><gtr:impact>PMID: 22528497.</gtr:impact><gtr:outcomeId>s6cjW2Fsvfb-1</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.</gtr:partnerContribution><gtr:piContribution>Intellectual and experimental contributions.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>New antituberculosis agents amongst known drugs.</gtr:description><gtr:id>09014EFF-B605-4203-A8E0-8829F24888FF</gtr:id><gtr:impact>PMID: 19699151.</gtr:impact><gtr:outcomeId>05434B4D3B7-1</gtr:outcomeId><gtr:partnerContribution>Designing of experiments and provision of compound library.</gtr:partnerContribution><gtr:piContribution>Designing and performing of experiments and analysis of results.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Montpellier</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Regulation of protein kinase activity in Mycobacterium tuberculosis.</gtr:description><gtr:id>2D0C24FC-C2B8-49FB-8D99-32B894670350</gtr:id><gtr:impact>PMID: 16040957. PMID: 19318624. PMID: 21134638. PMID: 21482481. PMID: 21622570.</gtr:impact><gtr:outcomeId>F58A774D5D2-3</gtr:outcomeId><gtr:partnerContribution>Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>cAMP receptor protein of Mycobacterium bovis BCG.</gtr:description><gtr:id>6D94FB50-D933-43A9-ABAF-C924DD47227F</gtr:id><gtr:impact>PMID: 18332206.</gtr:impact><gtr:outcomeId>590CCC49173-3</gtr:outcomeId><gtr:partnerContribution>Discussion of experiment design and results.Discussion of experiment design and results.Analysis of protein structures.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Molecular Biology and Biotechnology</gtr:department><gtr:description>Mechanism of action of the WhiB1 protein.</gtr:description><gtr:id>D5C6D4B3-944E-40CA-879A-12EAF6450065</gtr:id><gtr:impact>PMID: 20929442. PMID: 21182249. PMID: 22464736. PMID: 22792304.</gtr:impact><gtr:outcomeId>ZjDnysa5tXf-2</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental.Intellectual and experimental.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>Mycobacterium tuberculosis strains in a UK South Indian community.</gtr:description><gtr:id>A4A90A75-22CE-4357-AE21-C0D0303A9987</gtr:id><gtr:impact>PMID: 17719277.</gtr:impact><gtr:outcomeId>FDAC1CDB9E2-2</gtr:outcomeId><gtr:partnerContribution>Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA microarrays.Provision of DNA from clinical strains of Mycobacterium tuberculosis.</gtr:partnerContribution><gtr:piContribution>Designing and perfroming experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Regulation of protein kinase activity in Mycobacterium tuberculosis.</gtr:description><gtr:id>FFD84F8C-A534-41A7-96A1-07CDC35C542F</gtr:id><gtr:impact>PMID: 16040957. PMID: 19318624. PMID: 21134638. PMID: 21482481. PMID: 21622570.</gtr:impact><gtr:outcomeId>F58A774D5D2-1</gtr:outcomeId><gtr:partnerContribution>Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Mechanism of action of the WhiB1 protein.</gtr:description><gtr:id>CDA3D8B6-F792-44D6-989D-413C75F6D430</gtr:id><gtr:impact>PMID: 20929442. PMID: 21182249. PMID: 22464736. PMID: 22792304.</gtr:impact><gtr:outcomeId>ZjDnysa5tXf-4</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental.Intellectual and experimental.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cellular and Molecular Medicine</gtr:department><gtr:description>Mycobacterium tuberculosis strains in a UK South Indian community.</gtr:description><gtr:id>53BA5398-3550-4CC5-88B6-DAC3DE0BA417</gtr:id><gtr:impact>PMID: 17719277.</gtr:impact><gtr:outcomeId>FDAC1CDB9E2-3</gtr:outcomeId><gtr:partnerContribution>Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA microarrays.Provision of DNA from clinical strains of Mycobacterium tuberculosis.</gtr:partnerContribution><gtr:piContribution>Designing and perfroming experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cellular and Molecular Medicine</gtr:department><gtr:description>cAMP receptor protein of Mycobacterium tuberculosis.</gtr:description><gtr:id>ACAF148C-6A45-4719-A7BA-571DAA0362E6</gtr:id><gtr:impact>PMID: 15882420. Wellcome joint Project Grant (078731/Z/05/Z) with University of Sheffield - 2007. PMID:20028978. PMID:20929442.</gtr:impact><gtr:outcomeId>45A5A57F45E-2</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.Provision of DNA microarrays.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Mechanism of action of the WhiB1 protein.</gtr:description><gtr:id>BA588450-0562-4F62-AA04-213E20C69481</gtr:id><gtr:impact>PMID: 20929442. PMID: 21182249. PMID: 22464736. PMID: 22792304.</gtr:impact><gtr:outcomeId>ZjDnysa5tXf-3</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental.Intellectual and experimental.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Indian Institute of Science, Bangalore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>Department of Molecular Reproduction, Development and Genetics (MRDG)</gtr:department><gtr:description>Role of cAMP in mycobacteria.</gtr:description><gtr:id>D5FD4634-1237-4820-B518-43F84A41BCCE</gtr:id><gtr:impact>Royal Society International Travel Award - 2009.</gtr:impact><gtr:outcomeId>EA26F380DF0-1</gtr:outcomeId><gtr:partnerContribution>Intellectual discussions, experimental and provision of resources.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biochemistry and Microbiology Leeds</gtr:department><gtr:description>Mycobacterium tuberculosis strains in a UK South Indian community.</gtr:description><gtr:id>4649F66D-85A3-4128-8C50-493EC64FC3C0</gtr:id><gtr:impact>PMID: 17719277.</gtr:impact><gtr:outcomeId>FDAC1CDB9E2-4</gtr:outcomeId><gtr:partnerContribution>Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA microarrays.Provision of DNA from clinical strains of Mycobacterium tuberculosis.</gtr:partnerContribution><gtr:piContribution>Designing and perfroming experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Cardiovascular Disease</gtr:department><gtr:description>Mode of action of the EspR transcriptional regulator in Mycobacterium tuberculosis.</gtr:description><gtr:id>5224D244-4346-4007-AFB1-4607746E9455</gtr:id><gtr:impact>PMID: 22389481. PMID: 22722242</gtr:impact><gtr:outcomeId>RUKzcpabY6T-1</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.</gtr:partnerContribution><gtr:piContribution>Intellectual and experimental contributions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>cAMP receptor protein of Mycobacterium bovis BCG.</gtr:description><gtr:id>05E84BC9-395C-494D-8BBF-47F874A4405D</gtr:id><gtr:impact>PMID: 18332206.</gtr:impact><gtr:outcomeId>590CCC49173-1</gtr:outcomeId><gtr:partnerContribution>Discussion of experiment design and results.Discussion of experiment design and results.Analysis of protein structures.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Regulation of protein kinase activity in Mycobacterium tuberculosis.</gtr:description><gtr:id>0D87E3DD-87F4-432A-96F4-F50B13CE901B</gtr:id><gtr:impact>PMID: 16040957. PMID: 19318624. PMID: 21134638. PMID: 21482481. PMID: 21622570.</gtr:impact><gtr:outcomeId>F58A774D5D2-2</gtr:outcomeId><gtr:partnerContribution>Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.Designing and performing experiments and analysis of results.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>cAMP receptor protein of Mycobacterium bovis BCG.</gtr:description><gtr:id>8619CEDE-B96C-4798-9505-59BC03C1C57F</gtr:id><gtr:impact>PMID: 18332206.</gtr:impact><gtr:outcomeId>590CCC49173-2</gtr:outcomeId><gtr:partnerContribution>Discussion of experiment design and results.Discussion of experiment design and results.Analysis of protein structures.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Use of DNA microarrays to analyse genome expression in the macrophage.</gtr:description><gtr:id>0DECE2C3-4838-488B-A60F-9DE1D37E4C54</gtr:id><gtr:impact>PMID: 16782391. Yang, M; Krishnan, N; Coade, S; Buxton, RS; Hubank, M; Young, DB and Tascon, RE (2009) Activation by CpG oligodeoxynucleotide protects bone marrow derived dendritic cells from apoptosis: A transcriptomic and bio-informatic study. The Open Immunology Journal 2, 67-78</gtr:impact><gtr:outcomeId>9FF0F60D08B-1</gtr:outcomeId><gtr:partnerContribution>Designing and performing experiments and analysis of results.Designing and performing experimenst and analysis of results.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>cAMP receptor protein of Mycobacterium tuberculosis.</gtr:description><gtr:id>2C0AB765-0407-4D58-9524-AAA90866CFCC</gtr:id><gtr:impact>PMID: 15882420. Wellcome joint Project Grant (078731/Z/05/Z) with University of Sheffield - 2007. PMID:20028978. PMID:20929442.</gtr:impact><gtr:outcomeId>45A5A57F45E-1</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental contributions.Provision of DNA microarrays.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences UEA</gtr:department><gtr:description>Mechanism of action of the WhiB1 protein.</gtr:description><gtr:id>1E2C4633-69E6-4C35-93D0-33136EF9215C</gtr:id><gtr:impact>PMID: 20929442. PMID: 21182249. PMID: 22464736. PMID: 22792304.</gtr:impact><gtr:outcomeId>ZjDnysa5tXf-1</gtr:outcomeId><gtr:partnerContribution>Intellectual and experimental.Intellectual and experimental.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Molecular Bacteriology and Infection</gtr:department><gtr:description>Use of DNA microarrays to analyse genome expression in the macrophage.</gtr:description><gtr:id>7A6481DC-AEF7-401E-A26F-385F8C1EFC16</gtr:id><gtr:impact>PMID: 16782391. Yang, M; Krishnan, N; Coade, S; Buxton, RS; Hubank, M; Young, DB and Tascon, RE (2009) Activation by CpG oligodeoxynucleotide protects bone marrow derived dendritic cells from apoptosis: A transcriptomic and bio-informatic study. The Open Immunology Journal 2, 67-78</gtr:impact><gtr:outcomeId>9FF0F60D08B-2</gtr:outcomeId><gtr:partnerContribution>Designing and performing experiments and analysis of results.Designing and performing experimenst and analysis of results.</gtr:partnerContribution><gtr:piContribution>Designing and performing experiments and analysis of results.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Evaluation of inhibitors of Mycobacterium tuberculosis protein kinases.</gtr:description><gtr:id>B2554BD0-4518-4D53-A7C0-0F67FF6ABB42</gtr:id><gtr:impact>MRC-Technology Development Gap Fund award - 2006. PMID:21482481. PMID: 22469702.</gtr:impact><gtr:outcomeId>8892FD41FBA-2</gtr:outcomeId><gtr:partnerContribution>Screening of compound libraries, discussion and analysis of results.Intellectual and experimental.</gtr:partnerContribution><gtr:piContribution>In vitro and in vivo experiments to evaluate lead compounds, discussion and analysis of results.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birmingham Heartlands Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mycobacterium tuberculosis strains in a UK South Indian community.</gtr:description><gtr:id>F1747D7E-737C-4D01-986C-16B3ACE11FAD</gtr:id><gtr:impact>PMID: 17719277.</gtr:impact><gtr:outcomeId>FDAC1CDB9E2-1</gtr:outcomeId><gtr:partnerContribution>Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA from clinical strains of Mycobacterium tuberculosis.Provision of DNA microarrays.Provision of DNA from clinical strains of Mycobacterium tuberculosis.</gtr:partnerContribution><gtr:piContribution>Designing and perfroming experiments and analysis of results.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Schools visits - NIMR</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>03E1C358-6762-4DB8-BAEF-5A8FB6A7FF7E</gtr:id><gtr:impact>Talks given to primary school students.

NA</gtr:impact><gtr:outcomeId>EBF901BA490</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>107126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>E4C253AC-1E84-4DCA-8F75-69AD79746928</gtr:id><gtr:outcomeId>A566CCEDF360</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Joint Projects 2008/R2-2009</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>C16C3F9D-9910-4B8A-8CAA-E31037AFDCE7</gtr:id><gtr:outcomeId>DD6EE3951310</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>95254</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Joint Project Grant-2007</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AD5260D4-991C-49A3-B4B0-6E2AA21C1583</gtr:id><gtr:outcomeId>C801BC1C7250</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Deletion of Rv3616c (espA) gene in Mycobacterium tuberculosis.</gtr:description><gtr:id>7EAED893-7B00-4C70-A254-CC1C4CC627FB</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>dSfRhJaT93n</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rv3616c mutant</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Deletion of pknF gene in Mycobacterium tuberculosis.</gtr:description><gtr:id>72D3DB0F-162E-4787-B5E0-F85BF9B0BEEB</gtr:id><gtr:impact>PMID: 21622570. PMID: 23915284.</gtr:impact><gtr:outcomeId>jFqXNr82nPY</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PknF mutant.</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/21622570</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Deletion of whiB1 (Rv3219) gene of Mycobacterium tuberculosis.</gtr:description><gtr:id>6979CDC0-8AB1-4F9F-925C-FAEA04C60953</gtr:id><gtr:impact>PMID: 20929442.</gtr:impact><gtr:outcomeId>YVaArt1nowy</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>WhiB1 mutant</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/20929442</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Deletion of Rv1747 gene in Mycobacterium tuberculosis H37Rv.</gtr:description><gtr:id>DECDD89A-EFC6-42A6-A09A-8F6ADEA1781C</gtr:id><gtr:impact>PMID: 16040957. PMID: 21622570.</gtr:impact><gtr:outcomeId>F0DDC545169</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Rv1747 mutant.</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/16040957</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Deletion of espR (Rv3849) gene of Mycobacterium tuberculosis.</gtr:description><gtr:id>E2C665C3-B61F-458D-B33C-EC602A6D4016</gtr:id><gtr:impact>PMID: 22155774. PMID: 22389481. PMID: 22722242.</gtr:impact><gtr:outcomeId>cWm3oZr2pES</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EspR mutant.</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/22155774</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Deletion of Rv3676 gene in Mycobacterium tuberculosis H37Rv.</gtr:description><gtr:id>6A0F0E91-7586-469C-A0C0-9A19E86B693D</gtr:id><gtr:impact>PMID: 15882420. PMID: 20028978. PMID: 21902733.</gtr:impact><gtr:outcomeId>8D734B4FDD6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Rv3676 mutant.</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://europepmc.org/abstract/MED/15882420</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>27D0969E-AAA6-4755-890F-E8E00D4E75B5</gtr:id><gtr:title>Cmr is a redox-responsive regulator of DosR that contributes to M. tuberculosis virulence.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a7b186d8fcdc7.98819229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3925696-B09D-4186-8BDC-B2BC9D5A4071</gtr:id><gtr:title>Genome analysis shows a common evolutionary origin for the dominant strains of Mycobacterium tuberculosis in a UK South Asian community.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/636bc21ff329db9c5c472713694f24b0"><gtr:id>636bc21ff329db9c5c472713694f24b0</gtr:id><gtr:otherNames>Men?ndez MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>AA604DCEC3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C9DD931-7D04-4106-8DFF-651D55231DB1</gtr:id><gtr:title>An intramolecular switch regulates phosphoindependent FHA domain interactions in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Science signaling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cf3a5a8edf15b212e94edb95bb32f8e"><gtr:id>6cf3a5a8edf15b212e94edb95bb32f8e</gtr:id><gtr:otherNames>Nott TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1945-0877</gtr:issn><gtr:outcomeId>30A0385B82B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3492792-D82A-46D9-AF7F-9B135AF72E8B</gtr:id><gtr:title>Induced ectopic expression of HigB toxin in Mycobacterium tuberculosis results in growth inhibition, reduced abundance of a subset of mRNAs and cleavage of tmRNA.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a053a97f79a0ea87390b753ec11a83d8"><gtr:id>a053a97f79a0ea87390b753ec11a83d8</gtr:id><gtr:otherNames>Schuessler DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>pm_12866_26_23927792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38BAA428-2A37-4434-BA20-008FD4756292</gtr:id><gtr:title>Genomic mapping of cAMP receptor protein (CRP Mt) in Mycobacterium tuberculosis: relation to transcriptional start sites and the role of CRPMt as a transcription factor.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f35d846e6eecbe357796c579fa4d159"><gtr:id>7f35d846e6eecbe357796c579fa4d159</gtr:id><gtr:otherNames>Kahramanoglou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>544e07d697f973.28749790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D55735E-FE9A-4BD1-8BB9-62781E667693</gtr:id><gtr:title>Mycobacterium tuberculosis cAMP receptor protein (Rv3676) differs from the Escherichia coli paradigm in its cAMP binding and DNA binding properties and transcription activation properties.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f08e9b5aca877843e40ec45b36a487"><gtr:id>42f08e9b5aca877843e40ec45b36a487</gtr:id><gtr:otherNames>Stapleton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>SY7gfZd7iSR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2A971A1-9BF0-4F14-B899-46EAE114F596</gtr:id><gtr:title>Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0f0d2f0a76db496f8a5fbca8cdbc3d0"><gtr:id>e0f0d2f0a76db496f8a5fbca8cdbc3d0</gtr:id><gtr:otherNames>Chapman TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>pm_12866_26_22469702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3004994D-84A3-4891-A91F-A9DD90D7B93B</gtr:id><gtr:title>Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9992c8acc664d8a4cf35bcdfe307fbe"><gtr:id>b9992c8acc664d8a4cf35bcdfe307fbe</gtr:id><gtr:otherNames>Lougheed KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>hTbfAy57ZbR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03362716-2D0E-4226-A9E8-7EA7CB8E192F</gtr:id><gtr:title>Mycobacterium tuberculosis WhiB1 represses transcription of the essential chaperonin GroEL2.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c46837cca1c0c1e6950a16699597ee7a"><gtr:id>c46837cca1c0c1e6950a16699597ee7a</gtr:id><gtr:otherNames>Stapleton MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_12866_26_22464736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>344BFCA9-DD5F-48E3-9406-42B16B5B5736</gtr:id><gtr:title>Structure-function relationships of the Mycobacterium tuberculosis transcription factor WhiB1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>544e0829846df1.93575724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22A99F66-DF20-49F5-97A4-0974B1458220</gtr:id><gtr:title>Global analysis of the regulon of the transcriptional repressor LexA, a key component of SOS response in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5581febb9c647a6cbc3645650802b163"><gtr:id>5581febb9c647a6cbc3645650802b163</gtr:id><gtr:otherNames>Smollett KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12866_26_22528497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49A8BB7F-9615-4934-97C8-7D85D93B24ED</gtr:id><gtr:title>Activation by CpG Oligodeoxynucleotides Protects Bone Marrow-Derived Dendritic Cells from Apoptosis: A Transcriptomic and Bioinformatic Study</gtr:title><gtr:parentPublicationTitle>The Open Immunology Journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/568b1bdfe155aa165382b901542f1efb"><gtr:id>568b1bdfe155aa165382b901542f1efb</gtr:id><gtr:otherNames>Yang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>6534D8C41E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA842CE9-7C44-44F4-95D6-8C357A2545C4</gtr:id><gtr:title>Structural and functional analysis of phosphothreonine-dependent FHA domain interactions.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fd4f5c34c9b11065e73052abf4bc2a6"><gtr:id>7fd4f5c34c9b11065e73052abf4bc2a6</gtr:id><gtr:otherNames>Pennell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>eC65ALpjf47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C4ECB3A-B37C-4993-936D-936336073EB3</gtr:id><gtr:title>Overexpression of the Rv0805 phosphodiesterase elicits a cAMP-independent transcriptional response.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ce6419bd109564380cd652f1041e528"><gtr:id>4ce6419bd109564380cd652f1041e528</gtr:id><gtr:otherNames>Matange N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>544e06d6cb5a74.81189457</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E77B9C3-6EE1-4D24-B7AF-33B9D40C585C</gtr:id><gtr:title>Single nucleotide polymorphisms that cause structural changes in the cyclic AMP receptor protein transcriptional regulator of the tuberculosis vaccine strain Mycobacterium bovis BCG alter global gene expression without attenuating growth.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aad91a951d586d0c67b6a4409d933845"><gtr:id>aad91a951d586d0c67b6a4409d933845</gtr:id><gtr:otherNames>Hunt DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>D34956C1FB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA2892E-095C-4AAC-BA1A-EADB30EAC0CF</gtr:id><gtr:title>Long range transcriptional control of virulence critical genes in Mycobacterium tuberculosis by nucleoid-associated proteins?</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ad3191d3cd4e3207232e55002719dcb"><gtr:id>1ad3191d3cd4e3207232e55002719dcb</gtr:id><gtr:otherNames>Buxton RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>pm_12866_26_22389481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6777FAB9-8B59-451D-BDA9-63B500EE49C8</gtr:id><gtr:title>Forkhead-associated (FHA) domain containing ABC transporter Rv1747 is positively regulated by Ser/Thr phosphorylation in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7e3c448eed366a24793797e39ee075a"><gtr:id>e7e3c448eed366a24793797e39ee075a</gtr:id><gtr:otherNames>Spivey VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>He5UcpuPR8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F6D1008-2C7F-4FAF-8D7A-C9B1ED562346</gtr:id><gtr:title>An attenuated mutant of the Rv1747 ATP-binding cassette transporter of Mycobacterium tuberculosis and a mutant of its cognate kinase, PknF, show increased expression of the efflux pump-related iniBAC operon.</gtr:title><gtr:parentPublicationTitle>FEMS microbiology letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7e3c448eed366a24793797e39ee075a"><gtr:id>e7e3c448eed366a24793797e39ee075a</gtr:id><gtr:otherNames>Spivey VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0378-1097</gtr:issn><gtr:outcomeId>pm_12866_26_23915284</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB16FE3E-40C5-4AF7-9301-76FC53EAE866</gtr:id><gtr:title>New anti-tuberculosis agents amongst known drugs.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9992c8acc664d8a4cf35bcdfe307fbe"><gtr:id>b9992c8acc664d8a4cf35bcdfe307fbe</gtr:id><gtr:otherNames>Lougheed KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>D822CB048E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B91B11B-B899-4944-9B46-A726AF2A48D5</gtr:id><gtr:title>Mechanistic insight into the nitrosylation of the [4Fe-4S] cluster of WhiB-like proteins.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/694ba02098580a5f22edc8e62913e92f"><gtr:id>694ba02098580a5f22edc8e62913e92f</gtr:id><gtr:otherNames>Crack JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>b5roRe3HRS7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6141A9A-CC0F-41A5-810A-01438D0AC5C2</gtr:id><gtr:title>Structure of a Wbl protein and implications for NO sensing by M. tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3b442580e11d722842587290b1a7215"><gtr:id>b3b442580e11d722842587290b1a7215</gtr:id><gtr:otherNames>Kudhair BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a7b186dc29828.30742193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA5E0EB-37F0-4B4A-9688-DBC37FF55033</gtr:id><gtr:title>EspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18abd0f29d705f49559b8e894a5c0fa0"><gtr:id>18abd0f29d705f49559b8e894a5c0fa0</gtr:id><gtr:otherNames>Chen JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>pm_12866_26_22155774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39101A25-A0AB-490F-8CE3-9F7C8D1315FA</gtr:id><gtr:title>Novel regulatory roles of cAMP receptor proteins in fast-growing environmental mycobacteria.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f22e05a89725502d165e45ee84ca3c6c"><gtr:id>f22e05a89725502d165e45ee84ca3c6c</gtr:id><gtr:otherNames>Aung HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>5698cb764229b7.05054255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1EE6289-A430-4F52-8F51-D2AE9A609883</gtr:id><gtr:title>Comparative investigation of the pathogenicity of three Mycobacterium tuberculosis mutants defective in the synthesis of p-hydroxybenzoic acid derivatives.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/851be6c03d80b4224a18025653cf4ba8"><gtr:id>851be6c03d80b4224a18025653cf4ba8</gtr:id><gtr:otherNames>Stadthagen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>01F65DF15C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22434F7B-B336-42AD-8D9F-CCD6D2AA6021</gtr:id><gtr:title>Cyclic-AMP and bacterial cyclic-AMP receptor proteins revisited: adaptation for different ecological niches.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b6faf6b396223906a165c9cfe1f286"><gtr:id>97b6faf6b396223906a165c9cfe1f286</gtr:id><gtr:otherNames>Green J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>544e07741d22b7.67210580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>575EDF1D-AC27-4AEE-9529-CE89F83CEF5C</gtr:id><gtr:title>Mycobacterium tuberculosis WhiB1 is an essential DNA-binding protein with a nitric oxide-sensitive iron-sulfur cluster.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>C7Cgu9rNnNa</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117585867</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>